close
MENU
How to guide
How to guide
Home
The NBR List
NBR View
NBR Marketplace

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Investment
3 mins to read

US blow to major sleep device maker not a boon to F&P: analyst

Sleep devices made by Philips Respironics pulled from the market in the US, but the move may hold back other market players including F&P.

The Philips DreamStation 2 CPAP machine for home-based treatment of sleep apnoea.

Dita De Boni Wed, 31 Jan 2024

News that global breathing machine manufacturer Philips has been forced to stop selling its sleep apnoea devices in the US after the industrial foam used in the machines was found to be unsafe is not expected to hand a huge victory to New Zealand’s Fisher & Paykel Healthcare, a local analyst has

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Dita De Boni Wed, 31 Jan 2024
Contact the Writer: dita@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
F&P Healthcare sleep apnea philips ResMed
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Shoeshine

Has Fisher & Paykel Healthcare’s share price slide ended?
Shoeshine
1

F&P Healthcare investor reality check
Investment

F&P Healthcare says it’s nearly back to normal after Covid surges
General Business

Auckland land buy for F&P Appliances
Investment

F&P Healthcare’s shares jump with second-half growth tipped
Investment

F&P Healthcare expects consumables growth from Covid bump
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Shoeshine

Has Fisher & Paykel Healthcare’s share price slide ended?
Shoeshine
1

F&P Healthcare investor reality check
Investment

F&P Healthcare says it’s nearly back to normal after Covid surges
General Business

Auckland land buy for F&P Appliances
Investment

F&P Healthcare’s shares jump with second-half growth tipped
Investment

F&P Healthcare expects consumables growth from Covid bump
US blow to major sleep device maker not a boon to F&P: analyst
Investment,
102506
true
Subscribe Login